Literature DB >> 15663808

Ureteral endometriosis and coexistent urethral leiomyoma in a postmenopausal woman.

Andrew Strang1, Scott W Lisson, Steven P Petrou.   

Abstract

We report the case of a postmenopausal woman with a synchronous obstructing intrinsic endometrioma of the left ureter and a coexistent periurethral leiomyoma. Endometriosis in postmenopausal women is a rare clinical entity usually associated with exogenous estrogen use. Urethral leiomyomas are also rare, with only 40 cases reported in the literature. Ovarian hormones are believed to influence the growth of leiomyomas. We report the genitourinary presentation of 2 separate disease entities with known hormonal influence in a postmenopausal woman receiving estrogen replacement therapy. We believe the patient's hormonal milieu affected the development of her concurrent pathology.

Entities:  

Mesh:

Year:  2004        PMID: 15663808     DOI: 10.1590/s1677-55382004000600008

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  5 in total

Review 1.  Leiomyomas of the female urethra and bladder: a report of five cases and review of the literature.

Authors:  Sang Wook Bai; Hyun Joo Jung; Myung Jae Jeon; Da Jung Jung; Sei Kwang Kim; Jae Wook Kim
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-01

2.  Do symptomatic endometriosis and uterine fibroids appear together?

Authors:  Outi Uimari; Ilkka Järvelä; Markku Ryynänen
Journal:  J Hum Reprod Sci       Date:  2011-01

3.  [Leiomyoma of the bladder causing the destruction of a kidney].

Authors:  Mehdi Kehila; Karima Mekni; Hassine Saber Abouda; Maher Chtourou; Dorra Zeghal; Mohamed Badis Chanoufi
Journal:  Pan Afr Med J       Date:  2016-05-04

4.  Urethral Leiomyoma: A Rare Clinical Entity.

Authors:  Ng Beng Kwang; Aruku Naidu; Azyani Yahaya; Lim Pei Shan
Journal:  Case Rep Surg       Date:  2016-11-23

5.  Leiomyoma of the urethra: a rare benign tumor.

Authors:  Zhi Wen; Yang Liu; Peng Hao; XueSong Yang
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.